Table 3. Outcomes by days to OAC use.

OAC (oral anticoagulation), AE (adverse events), PE (pulmonary embolism), DVT (deep vein thrombosis)

	Overall  n=85	No OAC    n=32	< 7 days   n=32	7-14 days  n=10	>14 days  n=11
Days to receiving OAC, median (IQR*)	1 (0 – 5.5)	-	1 (1 - 2)	7 (7 – 9.5)	30 (24 – 31)
Complications**, n (%)
Death	27 (31.8)	22 (68.8)	2 (6.3)	1 (10.0)	2 (18.2)
Stroke	1 (1.2)	1 (3.1)	0 (0.0)	0 (0.0)	0 (0.0)
MI	7 (8.2)	5 (15.6)	1 (3.1)	0 (0.0)	1 (9.1)
Re-bleed	8 (9.4)	7 (21.9)	0 (0.0)	0 (0.0)	1 (9.1)
Pneumonia	2 (2.4)	2 (6.3)	0 (0.0)	0 (0.0)	0 (0.0)
Number of AEs
0	56 (65.9)	8 (25.0)	30 (93.8)	9 (90.0)	9 (81.8)
1	15 (17.6)	13 (40.6)	1 (3.1)	1 (10.0)	0 (0.0)
2	13 (15.3)	10 (31.3)	1 (3.1)	0 (0.0)	2 (18.2)
3	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)
4	1 (1.2)	1 (3.1)	0 (0.0)	0 (0.0)	0 (0.0)